ATHENS, Ga. & SAN JOSE, Calif.--(BUSINESS WIRE)--CyanVac LLC, a clinical-stage biotechnology company developing intranasal vaccines using a transformational parainfluenza virus 5 (PIV5)-based vector, ...
Live attenuated vaccines mimic natural infections, providing strong immunity but require refrigeration and caution for immunocompromised individuals. Subunit vaccines offer targeted immunity without ...
Vaccination is a cornerstone of public health, especially in the fight against respiratory viruses that cause seasonal illness. The landscape of vaccination has evolved significantly, with modern ...
Viral vectors are a key component of many advanced gene therapies and vaccines, but reliable, large-scale manufacturing remains a significant challenge. Continued innovation in vector design, cell ...
Nasal vaccines offer convenience and another option for those wary of needles, but traditional vaccines are best for young ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results